Abstract:Hepatitis B virus X protein (HBx) participates in the occurrence and development processes of hepatocellular carcinoma (HCC) as a multifunctional regulation factor. However, the underlying molecular mechanism remains obscure. Here, we describe the use of p21HBx/+ mouse and SILAM (Stable Isotope Labeling in Mammals) strategy to define the pathological mechanisms for the occurrence and development of HBx induced liver cancer. We systematically compared a series of proteome samples from regular mice, 12- and 24-month old p21HBx/+ mice representing the inflammation and HCC stages of liver disease respectively and their nontransgenic wild-type (WT) littermates. Totally we identified 22 and 97 differentially expressed proteins out of a total of 2473 quantified proteins. Bioinformatics analysis suggested that the lipid metabolism and CDC42-induced cytoskeleton remodeling pathways were strongly activated by the HBx transgene. Interestingly, the protein-protein interaction MS study revealed that HBx directly interacted with multiple proteins in these two pathways. The same effect of up-regulation of cytoskeleton and lipid metabolism related proteins, including CDC42, CFL1, PPARγ and ADFP, was also observed in the Huh-7 cells transfected with HBx. More importantly, CFL1 and ADFP were specifically accumulated in HBV-associated HCC (HBV-HCC) patient samples, and their expression levels were positively correlated with the severity of HBV-related liver disease. These results provide evidence that HBx induces the dysregulation of cytoskeleton remodeling and lipid metabolism and leads to the occurrence and development of liver cancer. The CFL1 and ADFP might be served as potential biomarkers for prognosis and diagnosis of HBV-HCC.

Progressive Changes in Hepatoma Cells Stably Transfected with Hepatitis B Virus X Gene

Hepatitis B virus X protein promotes hepatoma cell invasion and metastasis by stabilizing Snail protein

Dose-dependent modulation of cell apoptosis by hepatitis B virus X protein

Hepatocytes Treated With Hbv X Protein As Cytotoxic Effectors Kill Primary Hepatocytes By Tnf-Alpha-Related Apoptosis-Induced Ligand-Mediated Mechanism

Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma

Hepatitis B virus X protein inhibits autophagic degradation by impairing lysosomal maturation.

The Effects and Underlying Mechanisms of Hepatitis B Virus X Gene Mutants on the Development of Hepatocellular Carcinoma

Hepatitis B Virus X Protein Stimulates Proliferation, Wound Closure and Inhibits Apoptosis of HuH-7 Cells via CDC42

Hepatitis B Virus X Antigen (hbxag) and Cell Cycle Control in Chronic Infection and Hepatocarcinogenesis

[Mechanism and Clinical Significance of HBx-mediated Inhibition of CYP2E1 Expression in the Human HepG2 Hepatoma Cell Line].

Hepatitis B Virus X Induces Inflammation and Cancer in Mice Liver Through Dysregulation of Cytoskeletal Remodeling and Lipid Metabolism

HBx acts as an oncogene and promotes the invasion and metastasis of hepatocellular carcinoma both in vivo and vitro

Hepatitis B Virus X Protein Activates Notch Signaling By Its Effects On Notch1 And Notch4 In Human Hepatocellular Carcinoma

Hepatitis B Virus Whole-X and X Protein Play Distinct Roles in HBV-related Hepatocellular Carcinoma Progression.

Effects of hepatitis B virus X gene on apoptosis and expression of immune molecules of human proximal tubular epithelial cells

The Effect of HBx Protein on Gene Transcription in Huh7 Cells

[Role of HBx in hepatocellular carcinoma development].

Hepatitis B Virus X Protein (HBx) Suppresses Transcription Factor EB (TFEB) Resulting in Stabilization of Integrin Beta 1 (ITGB1) in Hepatocellular Carcinoma Cells

Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice

The mechanism of HBx protein to promote the initiation and progression of hepatocellular carcinoma

Hepatitis B Virus X Protein Contributes to Hepatocellular Carcinoma via Upregulation of KIAA1429 Methyltransferase and mRNA m6A Hypermethylation of HSPG2/Perlecan